首页> 外文期刊>Preventive Medicine Reports >The clinical utility of the AUSDRISK tool in assessing change in type 2 diabetes risk in overweight/obese volunteers undertaking a healthy lifestyle intervention
【24h】

The clinical utility of the AUSDRISK tool in assessing change in type 2 diabetes risk in overweight/obese volunteers undertaking a healthy lifestyle intervention

机译:AUSDRISK工具在评估接受健康生活方式干预的超重/肥胖志愿者中2型糖尿病风险变化的临床实用性

获取原文
           

摘要

The objective of this study was to assess the clinical utility of the AUSDRISK tool for determining risk of Type 2 diabetes mellitus (T2DM). In this secondary analysis from the HealthTrack study, the AUSDRISK tool was applied to data from overweight/obese volunteers completing a lifestyle intervention trial. Participants were volunteer residents of the Illawarra region recruited in 2014–2015. From 377 trial participants (BMI 25–40?kg/m2, 25–54?yr), 161 provided data required for measurement of AUSDRISK, collected at 0 and 12?months. They had been randomised to one of two lifestyle interventions (±a healthy food sample, 30?g walnuts/day, I and IW) delivered by dietitians, or a control intervention (C) delivered by nurse practitioners. HbA1c measures were considered for comparison. At baseline the AUSDRISK score indicatedn?=?83 (51.5%) were at high risk of T2DM within 5?years (≥12 points). After 12?months the proportion scored as high risk significantly decreased in the IW group (51.5% vs 33.3%;p?=?0.005), but not I (51.2% vs 39.0%;p?=?0.063) or C group (51.9% vs 38.9%;p?=?0.065). By comparison, HbA1c measures indicated high risk inn?=?24 (17%) of 139 participants at baseline and borderline non-significant changes over time in the randomised groups. In conclusion, the AUSDRISK tool has reasonable clinical utility in identifying T2DM risk in clinical samples of overweight/obese individuals.
机译:这项研究的目的是评估AUSDRISK工具在确定2型糖尿病(T2DM)风险中的临床效用。在HealthTrack研究的次要分析中,将AUSDRISK工具应用于超重/肥胖志愿者完成生活方式干预试验的数据。参与者是2014-2015年在伊拉瓦拉地区招募的志愿者。从377名试验参与者(BMI 25-40?kg / m2,25-54?yr)中,有161名提供了0和12个月时收集的AUSDRISK测量数据。他们被随机分为营养学家提供的两种生活方式干预措施(±健康食品样本,30克核桃/天,I和IW)或护士执业者采取的控制干预措施(C)中的一种。考虑使用HbA1c措施进行比较。基线时,AUSDRISK评分表明n == 83(51.5%)在5年内(≥12分)有高T2DM风险。 IW组在12个月后被评为高风险的比例显着下降(51.5%vs 33.3%; p?= 0.005),但I组(C组)则没有下降(51.2%vs 39.0%; p?= 0.063)。 51.9%比38.9%; p?=?0.065)。相比之下,HbA1c指标显示在基线时139名参与者的高风险inn?=?24(17%),随机组中的临界值随时间变化不显着。总之,AUSDRISK工具在识别超重/肥胖个体临床样本中的T2DM风险方面具有合理的临床实用性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号